Breaking News
Subscribe Now 0
📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI. See top stocks
Close

Bayer AG NA (BAY1)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
127.78 0.00    0.00%
04/10 - Delayed Data. Currency in PLN ( Disclaimer )
Type:  Equity
Market:  Poland
ISIN:  DE000BAY0017 
  • Volume: 0
  • Bid/Ask: 127.22 / 129.66
  • Day's Range: 126.68 - 129.66
Bayer 127.78 0.00 0.00%

Bayer AG Company Profile

 
Get an in-depth profile of Bayer AG NA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

98189

Equity Type

ORD

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Contact Information

Address Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
Phone 49 214 30 1
Fax -

Top Executives

Name Age Since Title
Norbert Winkeljohann 64 2018 Independent Chairman of Supervisory Board
Daniel Hartert 63 - Chairman of Executive Board - Bayer Business Services
Ertharin Cousin 65 2019 Independent Member of the Supervisory Board
Horst Baier 66 2020 Independent Member of Supervisory Board
Gunter Hilken 68 - Chairman of Executive Board - Currenta
Heike Hausfeld 59 2017 Vice Chairwoman of Supervisory Board
Heinz Georg Webers 65 2022 Employee Representative Member of Supervisory Board
Lori A. Schechter 62 2024 Independent Supervisory Board Member
Colleen A. Goggins 70 2017 Independent Member of Supervisory Board
Norbert W. Bischofberger 68 2017 Independent Member of Supervisory Board
Alberto Weisser 69 2021 Independent Supervisory Board Member
Otmar D. Wiestler 68 2014 Independent Member of Supervisory Board
Frank Löllgen 63 2015 Member of Supervisory Board
Francesco Grioli 52 2022 Employee Representative Member of the Supervisory Board
Claudia Schade 46 2022 Employee Representative Supervisory Board Member
Yasmin Fahimi 57 2022 Employee Representative Member of Supervisory Board
André van Broich 54 2012 Member of Supervisory Board
Barbara Gansewendt 61 2022 Employee Representative Supervisory Board Member
Simone Bagel-Trah 55 2014 Independent Member of Supervisory Board
Michael Westmeier 52 2022 Employee Representative Member of the Supervisory Board
Kimberly Mathisen 52 2022 Independent Member of the Supervisory Board
Nancy A. Simonian 63 2024 Independent Member of Supervisory Board
Andrea Sacher 43 2020 Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BAYGn Comments

Write your thoughts about Bayer AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email